The impact of next-generation sequencing on the DNA methylation-based translational cancer research
- PMID: 26687736
- DOI: 10.1016/j.trsl.2015.11.003
The impact of next-generation sequencing on the DNA methylation-based translational cancer research
Abstract
Epigenetics is currently in an exponential phase of growth, constituting one of the most promising fields in science, particularly in cancer research. Impaired epigenetic processes can lead to abnormal gene activity or inactivity, causing cellular disorders that are closely associated with tumor initiation and progression. Thus, there is a pivotal role of massive sequencing techniques for epigenetics, which aim to find novel biomarkers, factors of prognosis and prediction, and targets for achieving personalized treatments. We present a brief description of the evolution of next-generation sequencing technologies and its coupling with DNA methylation analysis techniques, highlighting its future in translational medicine and presenting significant findings in several malignancies. We also expose critical topics related to the implementation of these approaches, which is expected to be affordable for most research centers in the near future.
Copyright © 2016 Elsevier Inc. All rights reserved.
Similar articles
-
Profiling DNA Methylation Based on Next-Generation Sequencing Approaches: New Insights and Clinical Applications.Genes (Basel). 2018 Aug 23;9(9):429. doi: 10.3390/genes9090429. Genes (Basel). 2018. PMID: 30142958 Free PMC article. Review.
-
The potential of DNA modifications as biomarkers and therapeutic targets in oncology.Expert Rev Mol Diagn. 2015;15(10):1325-37. doi: 10.1586/14737159.2015.1084229. Epub 2015 Sep 7. Expert Rev Mol Diagn. 2015. PMID: 26394702 Review.
-
Next-generation sequencing technologies for DNA methylation analyses in cancer genomics.Epigenomics. 2010 Apr;2(2):199-207. doi: 10.2217/epi.09.50. Epigenomics. 2010. PMID: 22121870 Review.
-
The value of new high-throughput technologies for diagnosis and prognosis in solid tumors.Cancer Biomark. 2014;14(2-3):103-17. doi: 10.3233/CBM-130328. Cancer Biomark. 2014. PMID: 24878811 Review.
-
Epigenetic biomarkers in laboratory diagnostics: emerging approaches and opportunities.Expert Rev Mol Diagn. 2013 Jun;13(5):457-71. doi: 10.1586/erm.13.37. Expert Rev Mol Diagn. 2013. PMID: 23782253 Review.
Cited by
-
Can long-read sequencing tackle the barriers, which the next-generation could not? A review.Pathol Oncol Res. 2024 May 16;30:1611676. doi: 10.3389/pore.2024.1611676. eCollection 2024. Pathol Oncol Res. 2024. PMID: 38818014 Free PMC article. Review.
-
HBCR_DMR: A Hybrid Method Based on Beta-Binomial Bayesian Hierarchical Model and Combination of Ranking Method to Detect Differential Methylation Regions in Bisulfite Sequencing Data.J Pers Med. 2024 Mar 29;14(4):361. doi: 10.3390/jpm14040361. J Pers Med. 2024. PMID: 38672987 Free PMC article.
-
Identification and Analysis of Candidate Genes Associated with Yield Structure Traits and Maize Yield Using Next-Generation Sequencing Technology.Genes (Basel). 2023 Dec 29;15(1):56. doi: 10.3390/genes15010056. Genes (Basel). 2023. PMID: 38254946 Free PMC article.
-
DNA Methylation in the Fields of Prenatal Diagnosis and Early Detection of Cancers.Int J Mol Sci. 2023 Jul 20;24(14):11715. doi: 10.3390/ijms241411715. Int J Mol Sci. 2023. PMID: 37511475 Free PMC article. Review.
-
Shifting the Cancer Screening Paradigm: The Rising Potential of Blood-Based Multi-Cancer Early Detection Tests.Cells. 2023 Mar 18;12(6):935. doi: 10.3390/cells12060935. Cells. 2023. PMID: 36980276 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
